Altered SERCA Expression in Breast Cancer

Area of Science:

• Cellular Biology
• Molecular Oncology

Background:

• Calcium (Ca2+) signaling regulates vital cellular functions, with dysregulation implicated in cancer development.
• Sarco/endoplasmic reticulum Ca2+ ATPase pump (SERCA) proteins maintain intracellular Ca2+ homeostasis, and their altered expression is associated with various cancers, including breast cancer.

Purpose of the Study:

• To investigate the role of specific sarco/endoplasmic reticulum Ca2+ ATPase pump (SERCA) gene expressions in breast cancer.
• To determine the association between ATP2A1 and ATP2A3 gene expression and patient survival in breast cancer.

Main Methods:

• Analysis of breast cancer patient data from cBioPortal.
• Generation of Kaplan-Meier plots to assess survival rates based on ATP2A1 and ATP2A3 expression.
• Examination of SERCA gene expression in breast cancer cell lines.

Main Results:

• High expression of ATP2A1 and ATP2A3 was correlated with reduced patient survival.
• Significant differences in SERCA-specific gene expression were observed across breast cancer cell lines.
• Bioinformatics analysis revealed substantial alterations in ATP2A1 and ATP2A3 expression in breast cancer patients.

Conclusions:

• Specific sarco/endoplasmic reticulum Ca2+ ATPase pump (SERCA) gene expression patterns are altered in breast cancer.
• ATP2A1 and ATP2A3 expression levels may serve as prognostic indicators for breast cancer patients.
• Targeting SERCA gene expression holds potential for controlling breast cancer progression.